Huaiqihuang granule    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
63Idiopathic thrombocytopenic purpura1

63. Idiopathic thrombocytopenic purpura    [ 311 clinical trials,   185 drugs,   (DrugBank: 39 drugs),   43 drug target genes,   132 drug target pathways]
Searched query = "Idiopathic thrombocytopenic purpura", "Primary immune thrombocytopenia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 311 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03201848
(ClinicalTrials.gov)
November 16, 201727/6/2017The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune ThrombocytopeniaA Multisite, Randomized, Double-Blind, Placebo-Controlled, and Parallel Study to Evaluate the Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (Qi Yin Deficiency)Immune ThrombocytopeniaDrug: Placebo;Drug: Huaiqihuang GranuleQidong Gaitianli Medicines Co., LtdHuazhong University of Science and TechnologyRecruiting1 Year14 YearsAll216Phase 4China